Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 25 versus DEXTROSE 5 IN ACETATED RINGER S IN PLASTIC CONTAINER.
Head-to-head clinical analysis: DEXTROSE 25 versus DEXTROSE 5 IN ACETATED RINGER S IN PLASTIC CONTAINER.
DEXTROSE 25% vs DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose (D-glucose) is a monosaccharide that provides caloric support. It is transported into cells via glucose transporters (GLUTs) and undergoes glycolysis to produce ATP. It increases blood glucose levels, providing substrate for cellular metabolism.
Dextrose is a monosaccharide that provides caloric supplementation and serves as a source of glucose for cellular metabolism. Acetate in Ringer's solution is metabolized to bicarbonate, acting as an alkalinizing agent to correct acidosis. The electrolyte composition (sodium, potassium, calcium, chloride, magnesium, acetate) maintains fluid and electrolyte balance.
Adults: 25 grams (100 mL of 25% solution) intravenously as a single dose for hypoglycemia. May repeat if needed based on blood glucose monitoring.
Intravenous infusion, typically 1000-2000 mL per 24 hours, rate adjusted based on fluid and electrolyte needs.
None Documented
None Documented
Terminal half-life is approximately 30-60 minutes due to rapid cellular uptake and metabolism. Clinical context: In hyperinsulinemic states or insulin therapy, half-life is shortened; in renal/hepatic impairment, half-life may be prolonged but glucose is quickly cleared.
Not applicable; dextrose is rapidly metabolized and cleared; functional half-life of infused fluid is about 15–30 minutes via redistribution and renal excretion.
Dextrose is completely metabolized to carbon dioxide and water. Excretion: Renal (0% unchanged), Biliary/Fecal (negligible). Essentially 100% metabolized.
Renal: >95% as water; acetate and electrolytes are metabolized or excreted renally.
Category C
Category C
IV Fluid
IV Fluid